Immune-Based Antitumor Effects of BRAF Inhibitors Rely on Signaling by CD40L and IFNγ
(Q33776925)
scientific article published on April 15, 2014
scientific article published on April 15, 2014
Language:
Current Data About
Immune-Based Antitumor Effects of BRAF Inhibitors Rely on Signaling by CD40L and IFNγ